Dr. John Allan is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, New York-Presbyterian Hospital, and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Saint Louis University School of Medicine and has been in practice 8 years. He is one of 368 doctors at New York-Presbyterian Hospital and one of 115 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Oncology. He has more than 50 publications and over 500 citings.
Office
520 East 70th Street Starr Pavilion, 3rd Floor New York, NY 10021
Mateo Mejia Saldarriaga, Mohammad Alhomoud, Gail Roboz, John N Allan, Jia Ruan, Madhu M Ouseph, Paul D Simonson, Mark Bustoros, Ruben Niesvizky> ;American Journal of Hematology. 2023 Jul 1
Paul M Barr, Alessandra Tedeschi, William G Wierda, John N Allan, Paolo Ghia, Daniele Vallisa, Ryan Jacobs, Susan O'Brien, Andrew P Grigg, Patricia Walker, Cathy Zhou,...> ;Clinical Cancer Research. 2022 Oct 14
Rajat Bannerji, Jon E Arnason, Ranjana H Advani, Jennifer R Brown, John N Allan, Stephen M Ansell, Jeffrey A Barnes, Susan M O'Brien, Julio C Chávez, Johannes Duell, A...> ;The Lancet. Haematology. 2022 May 1
John N Allan, Javier Pinilla-Ibarz, Douglas E Gladstone, Krish Patel, Jeff P Sharman, William G Wierda, Michael Y Choi, Susan M O'Brien, Mazyar Shadman, Matthew S Davi...> ;Haematologica. 2022 Apr 1
John N Allan, Tait Shanafelt, Carol Moreno, Susan M O'Brien, Jianling Li, Gabriel Krigsfeld, James P Dean, Inhye E Ahn, Adrian Wiestner> ;British Journal of Haematology. 2022 Feb 1
Jorge J. Castillo, John N. Allan, Tanya Siddiqi, Ranjana H. Advani, Kirsten Meid, Carly Leventoff, Timothy P White, Catherine A Flynn, Shayna Sarosiek, Andrew R. Brana...> ;Journal of Clinical Oncology. 2021 Nov 18
William G. Wierda, John N. Allan, Tanya Siddiqi, Thomas J. Kipps, Stephen Opat, Alessandra Tedeschi, Xavier C. Badoux, Bryone J. Kuss, Sharon Jackson, Carol Moreno, Ry...> ;Journal of Clinical Oncology. 2021 Oct 7
Matthew S. Davids, Owen A. O'Connor, Wojciech Jurczak, Felipe Samaniego, Timothy S. Fenske, Pier Luigi Zinzani, Manish R. Patel, Nilanjan Ghosh, Bruce D. Cheson, Enric...> ;Blood Advances. 2021 Sep 21
Peter A. Forsberg, Adriana C Rossi, Angelique Boyer, Roger N. Pearse, Karen Pekle, David Jayabalan, Stephanie Lakritz, Kari Flicker, Drew Ribadeneyra, Brielle Liotta, ...> ;American Journal of Hematology. 2021 Sep 4
Lindsey E. Roeker, Toby A. Eyre, Meghan C. Thompson, Nicole Lamanna, Alexander Coltoff, Matthew S. Davids, PK Baker, Lori A. Leslie, Kerry A. Rogers, John N. Allan, Ra...> ;Blood. 2021 Jul 23
Andrea Iannello, Nicoletta Vitale, Silvia Coma, Francesca Arruga, Amy Chadburn, Arianna Di Napoli, Carlo Laudanna, John N. Allan, Richard R. Furman, Jonathan A. Pachte...> ;Blood. 2021 Jun 17
Kerry A. Rogers, Philip A. Thompson, John N. Allan, Morton Coleman, Jeff P. Sharman, Bruce D. Cheson, Dan Jones, Raquel Izumi, Melanie M. Frigault, Cheng Quah, Rakesh ...> ;Haematologica. 2021 Mar 18
Daniel R. Helbig, Ghaith Abu-Zeinah, Erica B. Bhavsar, Paul J. Christos, Richard R. Furman, John N. Allan> ;American Journal of Hematology. 2021 Feb 24
Tiziana Vaisitti, Francesca Arruga, Nicoletta Vitale, Thanh-Trang Lee, Mira Ko, Amy Chadburn, Esteban Braggio, Arianna Di Napoli, Andrea Iannello, John N. Allan, Langd...> ;Blood. 2021 Jun 17
Antonio Cuneo, Anthony R. Mato, Gian Matteo Rigolin, Alfonso Piciocchi, Massimo Gentile, Luca Laurenti, John N. Allan, John M. Pagel, Danielle M. Brander, Brian T. Hil...> ;Cancer Medicine. 2020 Sep 24
Chaitra S. Ujjani, Anthony R. Mato, Brian T. Hill, John N. Allan, Frederick Lansigan, Ryan Jacobs, Alan P Skarbnik, Hande H. Tuncer, John M. Pagel, Danielle M. Brander...> ;Blood and Lymphatic Cancer. 2020 Aug 24
Francesca Arruga, Valeria Bracciamà, Nicoletta Vitale, Tiziana Vaisitti, Katiuscia Gizzi, Alison Yeomans, Marta Coscia, Giovanni D'Arena, Gianluca Gaidano, John N Alla...> ;Leukemia. 2020 Jun 1
Yen-Chun Liu, Elizabeth Margolskee, John N. Allan, Susan Mathew, Erica B. Bhavsar, Joseph Casano, Attilio Orazi, Richard R. Furman, Julia T. Geyer> ;Modern Pathology. 2020 Mar 1
Toby A. Eyre, Lindsey E. Roeker, Christopher P. Fox, Satyen H. Gohill, Renata Walewska, Harriet S. Walter, Francesco Forconi, Angus Broom, Arvind Arumainathan, Daniell...> ;British Journal of Haematology. 2020 Mar 1
Toby A. Eyre, Nicole Lamanna, Lindsey E. Roeker, Chaitra S. Ujjani, Brian T. Hill, Paul M. Barr, Erick Lansigan, Bruce D. Cheson, Maryam Sarraf Yazdy, John N. Allan, J...> ;Haematologica. 2020 Feb 20
Anthony R. Mato, Lindsey E. Roeker, Ryan Jacobs, Brian T. Hill, Nicole Lamanna, Danielle M. Brander, Mazyar Shadman, Chaitra S. Ujjani, Maryam Sarraf Yazdy, Guilherme ...> ;Clinical Cancer Research. 2020 Jul 15
Real World Outcomes and Management Strategies for Venetoclax-Treated Chronic Lymphocytic Leukemia Patients in the United States
Arun K Singavi, Andrew Zelenetz, Nicole Lamanna, Bruce D Cheson, Richard R Furman, Jakub Svoboda, Stephen J Schuster, John N Allan, Chaitra S Ujjani, Haematologica
Abstracts/Posters
Vls-101 Is a Novel Therapeutic Antibody-Drug Conjugate (ADC) Targeting Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) in RichterÍs Syndrome (RS)
John N. Allan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Treatment Sequences and Outcomes of Patients with CLL Treated with Venetoclax and Other Novel Agents Post Introduction of Novel Therapies
John N. Allan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Ibrutinib (Ibr) Plus Venetoclax (Ven) for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL): Results from the MRD Cohort of t...
John N. Allan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Treatment Discontinuation Patterns for Patients with CLL in the Real-World Settings: Results from a Multi-Center Study
John N. Allan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Clinical Activity of REGN1979, a Bispecific Human, Anti-CD20 x Anti-CD3 Antibody, in Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-NHL)
John N. Allan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
The Dual PI3K-_/_ Inhibitor Duvelisib in Combination with the Bcl-2 Inhibitor Venetoclax Shows Promising Responses in Richter Syndrome-PDX Models
John N. Allan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Treatment Sequences and Outcomes of Patients with CLL Treated with Venetoclax and Other Novel Agents Post Introduction of Novel Therapies
John N. Allan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Molecular Genetics and Prognosis in Younger Patients with Chronic Lymphocytic Leukemia (CLL)
John N. Allan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Efficacy of Therapies Following Venetoclax Discontinuation in CLL: Focus on B-Cell Receptor Signal Transduction Inhibitors and Cellular Therapies
John N. Allan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Ongoing Results of a Phase 1B/2 Dose-Escalation and Cohort-Expansion Study of the Selective, Noncovalent, Reversible BrutonÍS Tyrosine Kinase Inhibitor, Vecabrutinib, ...
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
CD79b Expression in Richter's Transformation
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Emerging Clinical Activity of REGN1979, an Anti-CD20 x Anti‑CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Follicular Lymphoma (FL), Diffuse Large B-Cel...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
NOTCH1 Stabilization By PEST Mutations Enhances IgM-Mediated Activity in Chronic Lymphocytic Leukemia
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Hematopoietic Stem Cell Transplant in Novel Agent Era Is Associated with Improved Survival in Relapsed and Refractory Peripheral T-Cell Lymphoma
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2012 - 2015
Saint Louis University School of MedicineClass of 2009
NY State Medical License 2012 - 2025
Thanks. Feedback Improves Google AdsSeptember 17th, 2019
Fixed-Duration Ibrutinib plus Venetoclax Beneficial for LeukemiaJune 15th, 2023
New York-Presbyterian HospitalNew York, New York
NewYork-Presbyterian/Columbia University Irving Medical CenterNew York, New York
